Patents by Inventor Philip Ahring

Philip Ahring has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CATION CONDUCTING GABAA RECEPTORS AND THEIR USE
    Publication number: 20080033061
    Abstract: This invention relates to cation conducting GABAA receptors, mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the drug screening methods of the invention.
    Type: Application
    Filed: August 14, 2007
    Publication date: February 7, 2008
    Inventors: Marianne Jensen, Philip Ahring, Thomas Varming
  • Compositions and methods for modulating gated ion channels
    Publication number: 20080021034
    Abstract: The present invention relates to compositions and methods to modulate the activity of gated ion channels.
    Type: Application
    Filed: April 10, 2007
    Publication date: January 24, 2008
    Applicant: PainCeptor Pharma Corporation
    Inventors: Joachim Demnitz, Philip Ahring
  • Compositions and methods for modulating gated ion channels
    Publication number: 20080004272
    Abstract: The present invention relates to compositions and methods to modulate the activity of gated ion channels.
    Type: Application
    Filed: April 10, 2007
    Publication date: January 3, 2008
    Applicant: PainCeptor Pharma Corporation
    Inventors: Rahul Vohra, Chang-Qing Wei, Zhonghong Gan, Joachim Demnitz, Philip Ahring
  • Compositions and methods for modulating gated ion channels
    Publication number: 20070191418
    Abstract: The present invention relates to compositions and methods to modulate the activity of gated ion channels.
    Type: Application
    Filed: November 22, 2006
    Publication date: August 16, 2007
    Inventors: Rahul Vohra, Joachim Demnitz, Philip Ahring, Zhonghong Gan, Nachhattarpal Gill
  • Compositions and methods for modulating gated ion channels
    Publication number: 20070004680
    Abstract: The present invention relates to compositions and methods to modulate the activity of gated ion channels.
    Type: Application
    Filed: March 30, 2005
    Publication date: January 4, 2007
    Applicant: PainCeptor Pharma Corporation
    Inventors: Kazimierz Babinski, Walter Szarek, Rahul Vohra, Thomas Varming, Philip Ahring, Tino Joergensen, Gordon Blackburn-Munro
  • Novel quinuclidine derivatives and their pharmaceutical use
    Publication number: 20060217415
    Abstract: This invention relates to novel quinuclidine derivatives and their use as pharmaceuticals. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
    Type: Application
    Filed: June 29, 2004
    Publication date: September 28, 2006
    Applicant: ABBOTT LABORATORIES patent and Trademark Department
    Inventors: Dan Peters, Gunnar Olsen, Elsbert Nielsen, Philip Ahring, Tino Jorgensen, Michael Schrimpf, Kevin Sippy
  • Novel diazabicyclic aryl derivatives
    Publication number: 20060148789
    Abstract: This invention relates to novel diazabicyclic aryl derivatives which are found to be cholinergic ligands at the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
    Type: Application
    Filed: February 4, 2004
    Publication date: July 6, 2006
    Applicant: NEUROSEARCH A/S
    Inventors: Dan Peters, Elsebet Nielsen, Tino Jorgensen, Philip Ahring
  • Novel 1,4-diazabicycloalkane derivatives, their preparation and use
    Publication number: 20060122172
    Abstract: This invention relates to novel 1,4-diazabicycloalkane derivatives and their use in the manufacture of pharmaceutical compositions. The compounds of the invention are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
    Type: Application
    Filed: September 29, 2003
    Publication date: June 8, 2006
    Inventors: Dan Peters, Gunnar Olsen, Elsebet Nielsen, Tino Jorgensen, Philip Ahring
  • Novel quinuclidine derivatives and their use
    Publication number: 20050245567
    Abstract: This invention relates to novel quinuclidine derivatives and their use as pharmaceuticals. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
    Type: Application
    Filed: August 13, 2003
    Publication date: November 3, 2005
    Inventors: Dan Peters, Gunnar Olsen, Elsebet Nielsen, Philip Ahring, Tino Jorgensen
  • 3-Substituted quinuclidines and their use
    Publication number: 20050176756
    Abstract: This invention relates to novel 3-substituted quinuclidine derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neurodegeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
    Type: Application
    Filed: May 27, 2003
    Publication date: August 11, 2005
    Applicant: NeuroSearch A/S
    Inventors: Dan Peters, Gunnar Olsen, Elsebet Nielsen, Philip Ahring, Tino Jorgensen
  • Novel azacyclic ethynyl derivatives
    Publication number: 20050171078
    Abstract: This invention relates to novel azacyclic ethynyl derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
    Type: Application
    Filed: May 6, 2003
    Publication date: August 4, 2005
    Applicant: NEUROSEARCH
    Inventors: Dan Peters, Gunmar Olsen, Elsebet Nielsen, Tino Jorgensen, Philip Ahring
  • Novel diazabicyclic biaryl derivatives
    Publication number: 20050131236
    Abstract: This invention relates to novel diazabicyclic biaryl derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
    Type: Application
    Filed: May 6, 2003
    Publication date: June 16, 2005
    Inventors: Dan Peters, Gunnar Olsen, Elsebet Nielsen, Tino Jorgensen, Philip Ahring
  • Cation conducting gabaa receptors and their use
    Publication number: 20050049190
    Abstract: This invention relates to cation conducting GABAA receptors, mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the drug screening methods of the invention.
    Type: Application
    Filed: June 4, 2002
    Publication date: March 3, 2005
    Inventors: Marianne Jensen, Philip Ahring, Thomas Varming